Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 60.7017.583.14-40.091,061.31

What is the latest EBIT Growth ratio of VENUS REMEDIES ?

The latest EBIT Growth ratio of VENUS REMEDIES is 60.70 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202560.70
Mar202417.58
Mar20233.14
Mar2022-40.09
Mar20211,061.31

How is EBIT Growth of VENUS REMEDIES Trending?

Years EBIT Growth % Change
Mar2025 60.7
245.28
Mar2024 17.58
459.87
Mar2023 3.14
Positive
Mar2022 -40.09
Negative
Mar2021 1061.31 -

Other Financial Ratios of VENUS REMEDIES


Compare EBIT Growth ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹632.8 Cr -5.3% -0.8% 20.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹389,172.0 Cr 1.8% -3.6% -7.1% Stock Analytics
DIVIS LABORATORIES ₹158,248.0 Cr -2.8% -12.1% 24% Stock Analytics
CIPLA ₹122,835.0 Cr 2.3% 2.4% -4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,793.0 Cr 2.9% 6.5% 8.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,869.0 Cr 2% -2.4% -13.1% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-5.3%

-0.8%

20.7%

SENSEX

-0.6%

-2.8%

1.7%


You may also like the below Video Courses